The Intersection of Artificial Intelligence in Public Health and Personalized Cancer Therapy

Mudasir Rashid

doi:10.61927/igmin268

156 of 157

Technical & Economic Feasibility Study of Proposed Pump Storage Power Plants at Kuda Oya, Mul Oya, Gurugal Oya, and Dambagasthalawa

T Pirathapan, RCW Ponnamperuma, PMCPB Polgasdeniya and Tharanga Wickramarathna

END

Medicine Group Editorial 記事ID: igmin268

The Intersection of Artificial Intelligence in Public Health and Personalized Cancer Therapy

Obstetrics & Gynecology

Mudasir Rashid ^*

Affiliation

Department of Medicine and Cancer Center, Howard University Hospital, Washington DC, USA

DOI10.61927/igmin268 全文HTML 全文PDF この記事を引用する

要約

This editorial aims to highlight the critical intersections of patient care and technology, as illustrated in our recent article collection and addresses urgent challenges posed by global health crises like the COVID-19 pandemic while exploring broader themes such as personalized medicine, ethical practices, and the nutritional impacts on health. This diverse range of research highlights the necessity of interdisciplinary approaches to address the complexities of modern healthcare.

数字

参考文献

Mario C. Country risk to face global emergencies: negative effects of high public debt on health expenditures and fatality rate in COVID-19 pandemic crisis. IgMin Res. 2024;2:537-45.
Shakibfar S, Nyberg F, Li H, Zhao J, Nordeng HME, Sandve GKF, Pavlovic M, Hajiebrahimi M, Andersen M, Sessa M. Artificial intelligence-driven prediction of COVID-19-related hospitalization and death: a systematic review. Front Public Health. 2023 Jun 20;11:1183725. doi: 10.3389/fpubh.2023.1183725. PMID: 37408750; PMCID: PMC10319067.
Hasan MM, Islam MU, Sadeq MJ, Fung WK, Uddin J. Review on the Evaluation and Development of Artificial Intelligence for COVID-19 Containment. Sensors (Basel). 2023 Jan 3;23(1):527. doi: 10.3390/s23010527. PMID: 36617124; PMCID: PMC9824505.
Ahmadi Marzaleh M, Peyravi M, Mousavi S, Sarpourian F, Seyedi M, Shalyari N. Artificial Intelligence Functionalities During the COVID-19 Pandemic. Disaster Med Public Health Prep. 2023 Feb 27;17:e336. doi: 10.1017/dmp.2023.3. PMID: 36847255.
Farhat F, Sohail SS, Alam MT, Ubaid S, Shakil, Ashhad M, Madsen DØ. COVID-19 and beyond: leveraging artificial intelligence for enhanced outbreak control. Front Artif Intell. 2023 Nov 8;6:1266560. doi: 10.3389/frai.2023.1266560. PMID: 38028660; PMCID: PMC10663297.
Khan M, Mehran MT, Haq ZU, Ullah Z, Naqvi SR, Ihsan M, Abbass H. Applications of artificial intelligence in COVID-19 pandemic: A comprehensive review. Expert Syst Appl. 2021 Dec 15;185:115695. doi: 10.1016/j.eswa.2021.115695. Epub 2021 Aug 4. PMID: 34400854; PMCID: PMC8359727.
Wang L, Zhang Y, Wang D, Tong X, Liu T, Zhang S, Huang J, Zhang L, Chen L, Fan H, Clarke M. Artificial Intelligence for COVID-19: A Systematic Review. Front Med (Lausanne). 2021 Sep 30;8:704256. doi: 10.3389/fmed.2021.704256. PMID: 34660623; PMCID: PMC8514781.
Vaishya R, Javaid M, Khan IH, Haleem A. Artificial Intelligence (AI) applications for COVID-19 pandemic. Diabetes Metab Syndr. 2020 Jul-Aug;14(4):337-339. doi: 10.1016/j.dsx.2020.04.012. Epub 2020 Apr 14. PMID: 32305024; PMCID: PMC7195043.
Imad-Addin A. The power of artificial intelligence for improved patient outcomes, ethical practices, and overcoming challenges. IgMin Res. 2024;2:597-600.
Qazi Waqas K. A machine learning-based method for COVID-19 and pneumonia detection. IgMin Res. 2024;2:518-23.
Tajmirriahi M, Masjedi Esfahani M, Amouaghaei Z, Mansori N, Miralaei P, Lalehzar SS, Shirani P, Saadatnia M. Cardioembolic stroke, the most common subtype of stroke in COVID 19: A single center experience from Isfahan, Iran. J Res Med Sci. 2023 Feb 21;28:10. doi: 10.4103/jrms.jrms_594_21. PMID: 36974106; PMCID: PMC10039102.
Zuin M, Mazzitelli M, Rigatelli G, Bilato C, Cattelan AM. Risk of ischemic stroke in patients recovered from COVID-19 infection: A systematic review and meta-analysis. Eur Stroke J. 2023 Dec;8(4):915-922. doi: 10.1177/23969873231190432. Epub 2023 Jul 25. PMID: 37491810; PMCID: PMC10372514.
Ferrone SR, Sanmartin MX, Ohara J, Jimenez JC, Feizullayeva C, Lodato Z, Shahsavarani S, Lacher G, Demissie S, Vialet JM, White TG, Wang JJ, Katz JM, Sanelli PC. Acute ischemic stroke outcomes in patients with COVID-19: a systematic review and meta-analysis. J Neurointerv Surg. 2024 Mar 14;16(4):333-341. doi: 10.1136/jnis-2023-020489. PMID: 37460215.
Libruder C, Hershkovitz Y, Ben-Yaish S, Tanne D, Keinan-Boker L, Binyaminy B. An Increased Risk for Ischemic Stroke in the Short-Term Period following COVID-19 Infection: A Nationwide Population-Based Study. Neuroepidemiology. 2023;57(4):253-259. doi: 10.1159/000531163. Epub 2023 Jul 3. PMID: 37399799; PMCID: PMC11251667.
Anastasia V, Sergey S, Anastasia S, Tatyana V, Igor V. The model for clinical, laboratory, and genetic prediction of recurrent ischemic stroke against the background of laboratory aspirin resistance using machine learning. IgMin Res. 2024;2:39-44.
Roman-Gonzalez A, Naranjo CA, Cardona-Maya WD, Vallejo D, Garcia F, Franco C, Alvarez L, Tobón LI, López MI, Rua C, Bedoya G, Cadavid Á, Torres JD. Frequency of Aspirin Resistance in Ischemic Stroke Patients and Healthy Controls from Colombia. Stroke Res Treat. 2021 May 21;2021:9924710. doi: 10.1155/2021/9924710. PMID: 34094500; PMCID: PMC8164531.
Darya S, Ksenia F, Elizaveta S, Tatyana S, Yulia Z. Study of the histological features of the stroma of high-grade gliomas depending on the status of the mutation in the IDH1 gene. IgMin Res. 2024;2:702-8.
Richardson TE, Hatanpaa KJ, Walker JM. Molecular Characterization of "True" Low-Grade IDH-Wildtype Astrocytomas. J Neuropathol Exp Neurol. 2021 Apr 16;80(5):431-435. doi: 10.1093/jnen/nlab023. PMID: 33829259.
Álvarez-Torres MDM, López-Cerdán A, Andreu Z, de la Iglesia Vayá M, Fuster-Garcia E, García-García F, García-Gómez JM. Vascular differences between IDH-wildtype glioblastoma and astrocytoma IDH-mutant grade 4 at imaging and transcriptomic levels. NMR Biomed. 2023 Nov;36(11):e5004. doi: 10.1002/nbm.5004. Epub 2023 Jul 21. PMID: 37482922.
Simion CI, Elena Violeta C, Costin George F, Teodora Elena T, Cosmin B, Anwar E, et al. Diagnostic challenges in pancreatic tumors. IgMin Res. 2024;2:348-53.
González-Gómez R, Pazo-Cid RA, Sarría L, Morcillo MÁ, Schuhmacher AJ. Diagnosis of Pancreatic Ductal Adenocarcinoma by Immuno-Positron Emission Tomography. J Clin Med. 2021 Mar 10;10(6):1151. doi: 10.3390/jcm10061151. PMID: 33801810; PMCID: PMC8000738.
Miura F, Takada T, Amano H, Yoshida M, Furui S, Takeshita K. Diagnosis of pancreatic cancer. HPB (Oxford). 2006;8(5):337-42. doi: 10.1080/13651820500540949. PMID: 18333085; PMCID: PMC2020745.
González DG, Asensio DE, Pinto FP, Pérez SB, Pacheco SD. Peritoneal carcinomatosis from ovarian cancer: a case report. IgMin Res. 2024;2:309-12.
Della Corte L, Conte C, Palumbo M, Guerra S, Colacurci D, Riemma G, De Franciscis P, Giampaolino P, Fagotti A, Bifulco G, Scambia G. Hyperthermic Intraperitoneal Chemotherapy (HIPEC): New Approaches and Controversies on the Treatment of Advanced Epithelial Ovarian Cancer-Systematic Review and Meta-Analysis. J Clin Med. 2023 Nov 9;12(22):7012. doi: 10.3390/jcm12227012. PMID: 38002626; PMCID: PMC10672052.
van Driel WJ, Koole SN, Sikorska K, Schagen van Leeuwen JH, Schreuder HWR, Hermans RHM, de Hingh IHJT, van der Velden J, Arts HJ, Massuger LFAG, Aalbers AGJ, Verwaal VJ, Kieffer JM, Van de Vijver KK, van Tinteren H, Aaronson NK, Sonke GS. Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer. N Engl J Med. 2018 Jan 18;378(3):230-240. doi: 10.1056/NEJMoa1708618. PMID: 29342393.
Fabrizio P, Daria C, Ugo P, Gabriella T, Luigi M. Preventing rectal toxicity in prostate cancer: diet and supplement alternative to enemas or rectal spacer. IgMin Res. 2024;2:171-6.
Schaefer C, Zamboglou C, Volegova-Neher N, Martini C, Nicolay NH, Schmidt-Hegemann NS, Rogowski P, Li M, Belka C, Müller AC, Grosu AL, Brunner T. Impact of a low FODMAP diet on the amount of rectal gas and rectal volume during radiotherapy in patients with prostate cancer - a prospective pilot study. Radiat Oncol. 2020 Jan 30;15(1):27. doi: 10.1186/s13014-020-1474-y. PMID: 32000818; PMCID: PMC6993432.
Valdagni R, Rancati T. Reducing rectal injury during external beam radiotherapy for prostate cancer. Nat Rev Urol. 2013 Jun;10(6):345-57. doi: 10.1038/nrurol.2013.96. Epub 2013 May 14. PMID: 23670182.
Zaira G, Asia G. Breast cancer: the road to a personalized prevention. IgMin Res. 2024;2:163-70.
Prades J, Remue E, van Hoof E, Borras JM. Is it worth reorganising cancer services on the basis of multidisciplinary teams (MDTs)? A systematic review of the objectives and organisation of MDTs and their impact on patient outcomes. Health Policy. 2015 Apr;119(4):464-74. doi: 10.1016/j.healthpol.2014.09.006. Epub 2014 Sep 18. PMID: 25271171.
Capobianco AML, Gallucci G, Lapadula L, Dinardo G, La Torre G, Sisti N, Sisti LG. Impact of the Multidisciplinary Cancer Team on the Diagnostic and Therapeutic Care Pathway of Early Breast Cancer Patients and Perception of Team Members: The Experience of a Cancer Centre in Italy. Cancer Invest. 2024 Jan;42(1):12-20. doi: 10.1080/07357907.2023.2300442. Epub 2024 Jan 22. PMID: 38149612.
Lyman GH, Baker J, Geradts J, Horton J, Kimmick G, Peppercorn J, Pruitt S, Scheri RP, Hwang ES. Multidisciplinary care of patients with early-stage breast cancer. Surg Oncol Clin N Am. 2013 Apr;22(2):299-317. doi: 10.1016/j.soc.2012.12.005. Epub 2013 Jan 3. PMID: 23453336.
Kočo L, Weekenstroo HHA, Lambregts DMJ, Sedelaar JPM, Prokop M, Fütterer JJ, Mann RM. The Effects of Multidisciplinary Team Meetings on Clinical Practice for Colorectal, Lung, Prostate and Breast Cancer: A Systematic Review. Cancers (Basel). 2021 Aug 18;13(16):4159. doi: 10.3390/cancers13164159. PMID: 34439312; PMCID: PMC8394238.
El Hamsas EY, Omaima B, Zineb S, Najat EA, Driss R. The antioxidant and antidepressant properties of dietary proteins derived from egg and bean extracts and their acute toxicity: a journey from nutrition to pharmacognosy. IgMin Res. 2023;1:032-42.
Steingart AB, Cotterchio M. Do antidepressants cause, promote, or inhibit cancers? J Clin Epidemiol. 1995 Nov;48(11):1407-12. doi: 10.1016/0895-4356(95)00545-5. PMID: 7490604.
Zhuang Y, Pang X, Qi Y, Zhang T, Cao G, Xue H, Xu Y, Xie S, Liu Y, Wang Y, Li Y, Xiong Y, Li Y, Shen H. The incidence risk of breast and gynecological cancer by antidepressant use: A systematic review and dose-response meta-analysis of epidemiological studies involving 160,727 patients. Front Oncol. 2022 Oct 14;12:939636. doi: 10.3389/fonc.2022.939636. PMID: 36425551; PMCID: PMC9680975.
Abadi B, Shahsavani Y, Faramarzpour M, Rezaei N, Rahimi HR. Antidepressants with anti-tumor potential in treating glioblastoma: A narrative review. Fundam Clin Pharmacol. 2022 Feb;36(1):35-48. doi: 10.1111/fcp.12712. Epub 2021 Jul 29. PMID: 34212424.
Luo M, Zhou L, Huang Z, Li B, Nice EC, Xu J, Huang C. Antioxidant Therapy in Cancer: Rationale and Progress. Antioxidants (Basel). 2022 Jun 8;11(6):1128. doi: 10.3390/antiox11061128. PMID: 35740025; PMCID: PMC9220137.
Liao J, Li X, Gan Y, Han S, Rong P, Wang W, Li W, Zhou L. Artificial intelligence assists precision medicine in cancer treatment. Front Oncol. 2023 Jan 4;12:998222. doi: 10.3389/fonc.2022.998222. PMID: 36686757; PMCID: PMC9846804.
Rezayi S, R Niakan Kalhori S, Saeedi S. Effectiveness of Artificial Intelligence for Personalized Medicine in Neoplasms: A Systematic Review. Biomed Res Int. 2022 Apr 7;2022:7842566. doi: 10.1155/2022/7842566. PMID: 35434134; PMCID: PMC9010213.
Bhinder B, Gilvary C, Madhukar NS, Elemento O. Artificial Intelligence in Cancer Research and Precision Medicine. Cancer Discov. 2021 Apr;11(4):900-915. doi: 10.1158/2159-8290.CD-21-0090. PMID: 33811123; PMCID: PMC8034385.
Ho D. Artificial intelligence in cancer therapy. Science. 2020 Feb 28;367(6481):982-983. doi: 10.1126/science.aaz3023. PMID: 32108102.
Chen ZH, Lin L, Wu CF, Li CF, Xu RH, Sun Y. Artificial intelligence for assisting cancer diagnosis and treatment in the era of precision medicine. Cancer Commun (Lond). 2021 Nov;41(11):1100-1115. doi: 10.1002/cac2.12215. Epub 2021 Oct 6. PMID: 34613667; PMCID: PMC8626610.
Cè M, Irmici G, Foschini C, Danesini GM, Falsitta LV, Serio ML, Fontana A, Martinenghi C, Oliva G, Cellina M. Artificial Intelligence in Brain Tumor Imaging: A Step toward Personalized Medicine. Curr Oncol. 2023 Feb 22;30(3):2673-2701. doi: 10.3390/curroncol30030203. PMID: 36975416; PMCID: PMC10047107.

類似の記事

Comments to Megascopic Quantum Phenomena
Michal Svrček
DOI10.61927/igmin163

A Machine Learning-based Method for COVID-19 and Pneumonia Detection
Qazi Waqas Khan
DOI10.61927/igmin211

Threat to Human and Animal Health Caused by Mycotoxins and Masked Mycotoxins Occurring in Food and Feed
Anna Pikulicka and Wiesław Barabasz
DOI10.61927/igmin162

Prevalence of Diabetic Retinopathy among Self-reported Newly Diagnosed Diabetics
Shweta Walia
DOI10.61927/igmin190

The Imperative for Modern Public Cloud Providers to Upgrade Their Data Centers
Taha Sajid
DOI10.61927/igmin225

Problem of Surface Waves on Water in Higher School Laboratory Workshop
Chkhartishvili L, Chikhladze M and Kantaria I
DOI10.61927/igmin255

A Survey of Motion Data Processing and Classification Techniques Based on Wearable Sensors
Xiaoqiong Xiong, Xuemei Xiong, Chao Lian and Keda Zeng
DOI10.61927/igmin123

Use of Augmented Reality as a Radiation-free Alternative in Pain Management Spinal Surgeries
Songyuan Lu, Jingwen Hui, Eric Lee, Darin Tsui, Farshad M Ahadian and Frank E Talke*
DOI10.61927/igmin236

A New Physical Phenomenon Discovered When Microbiology Meets Surrealism: The Yoshida Effect has the Power to Fuse Bacteria and Nano-Acicular Materials
Naoto Yoshida
DOI10.61927/igmin233

Technical & Economic Feasibility Study of Proposed Pump Storage Power Plants at Kuda Oya, Mul Oya, Gurugal Oya, and Dambagasthalawa
T Pirathapan, RCW Ponnamperuma, PMCPB Polgasdeniya and Tharanga Wickramarathna
DOI10.61927/igmin267

ソーシャルアイコン

研究を公開する

私たちは、科学、技術、工学、医学に関する幅広い種類の記事を編集上の偏見なく公開しています。

提出する

見る原稿のガイドライン追加論文処理料

IgMin 科目を探索する

トップ10の記事をクリック

クイックリンク

原稿を提出する

研究論文

グーグルスカラー

Google Scholarは2004年11月にベータ版が発表され、幅広い学術領域を航海する学術ナビゲーターとして機能します。それは査読付きジャーナル、書籍、会議論文、論文、博士論文、プレプリント、要約、技術報告書、裁判所の意見、特許をカバーしています。 IgMin の記事を検索

[1] Mario C. Country risk to face global emergencies: negative effects of high public debt on health expenditures and fatality rate in COVID-19 pandemic crisis. IgMin Res. 2024;2:537-45.

[2] Shakibfar S, Nyberg F, Li H, Zhao J, Nordeng HME, Sandve GKF, Pavlovic M, Hajiebrahimi M, Andersen M, Sessa M. Artificial intelligence-driven prediction of COVID-19-related hospitalization and death: a systematic review. Front Public Health. 2023 Jun 20;11:1183725. doi: 10.3389/fpubh.2023.1183725. PMID: 37408750; PMCID: PMC10319067.

[3] Hasan MM, Islam MU, Sadeq MJ, Fung WK, Uddin J. Review on the Evaluation and Development of Artificial Intelligence for COVID-19 Containment. Sensors (Basel). 2023 Jan 3;23(1):527. doi: 10.3390/s23010527. PMID: 36617124; PMCID: PMC9824505.

[4] Ahmadi Marzaleh M, Peyravi M, Mousavi S, Sarpourian F, Seyedi M, Shalyari N. Artificial Intelligence Functionalities During the COVID-19 Pandemic. Disaster Med Public Health Prep. 2023 Feb 27;17:e336. doi: 10.1017/dmp.2023.3. PMID: 36847255.

[5] Farhat F, Sohail SS, Alam MT, Ubaid S, Shakil, Ashhad M, Madsen DØ. COVID-19 and beyond: leveraging artificial intelligence for enhanced outbreak control. Front Artif Intell. 2023 Nov 8;6:1266560. doi: 10.3389/frai.2023.1266560. PMID: 38028660; PMCID: PMC10663297.

[6] Khan M, Mehran MT, Haq ZU, Ullah Z, Naqvi SR, Ihsan M, Abbass H. Applications of artificial intelligence in COVID-19 pandemic: A comprehensive review. Expert Syst Appl. 2021 Dec 15;185:115695. doi: 10.1016/j.eswa.2021.115695. Epub 2021 Aug 4. PMID: 34400854; PMCID: PMC8359727.

[7] Wang L, Zhang Y, Wang D, Tong X, Liu T, Zhang S, Huang J, Zhang L, Chen L, Fan H, Clarke M. Artificial Intelligence for COVID-19: A Systematic Review. Front Med (Lausanne). 2021 Sep 30;8:704256. doi: 10.3389/fmed.2021.704256. PMID: 34660623; PMCID: PMC8514781.

[8] Vaishya R, Javaid M, Khan IH, Haleem A. Artificial Intelligence (AI) applications for COVID-19 pandemic. Diabetes Metab Syndr. 2020 Jul-Aug;14(4):337-339. doi: 10.1016/j.dsx.2020.04.012. Epub 2020 Apr 14. PMID: 32305024; PMCID: PMC7195043.

[9] Imad-Addin A. The power of artificial intelligence for improved patient outcomes, ethical practices, and overcoming challenges. IgMin Res. 2024;2:597-600.

[10] Qazi Waqas K. A machine learning-based method for COVID-19 and pneumonia detection. IgMin Res. 2024;2:518-23.

[11] Tajmirriahi M, Masjedi Esfahani M, Amouaghaei Z, Mansori N, Miralaei P, Lalehzar SS, Shirani P, Saadatnia M. Cardioembolic stroke, the most common subtype of stroke in COVID 19: A single center experience from Isfahan, Iran. J Res Med Sci. 2023 Feb 21;28:10. doi: 10.4103/jrms.jrms_594_21. PMID: 36974106; PMCID: PMC10039102.

[12] Zuin M, Mazzitelli M, Rigatelli G, Bilato C, Cattelan AM. Risk of ischemic stroke in patients recovered from COVID-19 infection: A systematic review and meta-analysis. Eur Stroke J. 2023 Dec;8(4):915-922. doi: 10.1177/23969873231190432. Epub 2023 Jul 25. PMID: 37491810; PMCID: PMC10372514.

[13] Ferrone SR, Sanmartin MX, Ohara J, Jimenez JC, Feizullayeva C, Lodato Z, Shahsavarani S, Lacher G, Demissie S, Vialet JM, White TG, Wang JJ, Katz JM, Sanelli PC. Acute ischemic stroke outcomes in patients with COVID-19: a systematic review and meta-analysis. J Neurointerv Surg. 2024 Mar 14;16(4):333-341. doi: 10.1136/jnis-2023-020489. PMID: 37460215.

[14] Libruder C, Hershkovitz Y, Ben-Yaish S, Tanne D, Keinan-Boker L, Binyaminy B. An Increased Risk for Ischemic Stroke in the Short-Term Period following COVID-19 Infection: A Nationwide Population-Based Study. Neuroepidemiology. 2023;57(4):253-259. doi: 10.1159/000531163. Epub 2023 Jul 3. PMID: 37399799; PMCID: PMC11251667.

[15] Anastasia V, Sergey S, Anastasia S, Tatyana V, Igor V. The model for clinical, laboratory, and genetic prediction of recurrent ischemic stroke against the background of laboratory aspirin resistance using machine learning. IgMin Res. 2024;2:39-44.

[16] Roman-Gonzalez A, Naranjo CA, Cardona-Maya WD, Vallejo D, Garcia F, Franco C, Alvarez L, Tobón LI, López MI, Rua C, Bedoya G, Cadavid Á, Torres JD. Frequency of Aspirin Resistance in Ischemic Stroke Patients and Healthy Controls from Colombia. Stroke Res Treat. 2021 May 21;2021:9924710. doi: 10.1155/2021/9924710. PMID: 34094500; PMCID: PMC8164531.

[17] Darya S, Ksenia F, Elizaveta S, Tatyana S, Yulia Z. Study of the histological features of the stroma of high-grade gliomas depending on the status of the mutation in the IDH1 gene. IgMin Res. 2024;2:702-8.

[18] Richardson TE, Hatanpaa KJ, Walker JM. Molecular Characterization of "True" Low-Grade IDH-Wildtype Astrocytomas. J Neuropathol Exp Neurol. 2021 Apr 16;80(5):431-435. doi: 10.1093/jnen/nlab023. PMID: 33829259.

[19] Álvarez-Torres MDM, López-Cerdán A, Andreu Z, de la Iglesia Vayá M, Fuster-Garcia E, García-García F, García-Gómez JM. Vascular differences between IDH-wildtype glioblastoma and astrocytoma IDH-mutant grade 4 at imaging and transcriptomic levels. NMR Biomed. 2023 Nov;36(11):e5004. doi: 10.1002/nbm.5004. Epub 2023 Jul 21. PMID: 37482922.

[20] Simion CI, Elena Violeta C, Costin George F, Teodora Elena T, Cosmin B, Anwar E, et al. Diagnostic challenges in pancreatic tumors. IgMin Res. 2024;2:348-53.

[21] González-Gómez R, Pazo-Cid RA, Sarría L, Morcillo MÁ, Schuhmacher AJ. Diagnosis of Pancreatic Ductal Adenocarcinoma by Immuno-Positron Emission Tomography. J Clin Med. 2021 Mar 10;10(6):1151. doi: 10.3390/jcm10061151. PMID: 33801810; PMCID: PMC8000738.

[22] Miura F, Takada T, Amano H, Yoshida M, Furui S, Takeshita K. Diagnosis of pancreatic cancer. HPB (Oxford). 2006;8(5):337-42. doi: 10.1080/13651820500540949. PMID: 18333085; PMCID: PMC2020745.

[23] González DG, Asensio DE, Pinto FP, Pérez SB, Pacheco SD. Peritoneal carcinomatosis from ovarian cancer: a case report. IgMin Res. 2024;2:309-12.

[24] Della Corte L, Conte C, Palumbo M, Guerra S, Colacurci D, Riemma G, De Franciscis P, Giampaolino P, Fagotti A, Bifulco G, Scambia G. Hyperthermic Intraperitoneal Chemotherapy (HIPEC): New Approaches and Controversies on the Treatment of Advanced Epithelial Ovarian Cancer-Systematic Review and Meta-Analysis. J Clin Med. 2023 Nov 9;12(22):7012. doi: 10.3390/jcm12227012. PMID: 38002626; PMCID: PMC10672052.

[25] van Driel WJ, Koole SN, Sikorska K, Schagen van Leeuwen JH, Schreuder HWR, Hermans RHM, de Hingh IHJT, van der Velden J, Arts HJ, Massuger LFAG, Aalbers AGJ, Verwaal VJ, Kieffer JM, Van de Vijver KK, van Tinteren H, Aaronson NK, Sonke GS. Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer. N Engl J Med. 2018 Jan 18;378(3):230-240. doi: 10.1056/NEJMoa1708618. PMID: 29342393.

[26] Fabrizio P, Daria C, Ugo P, Gabriella T, Luigi M. Preventing rectal toxicity in prostate cancer: diet and supplement alternative to enemas or rectal spacer. IgMin Res. 2024;2:171-6.

[27] Schaefer C, Zamboglou C, Volegova-Neher N, Martini C, Nicolay NH, Schmidt-Hegemann NS, Rogowski P, Li M, Belka C, Müller AC, Grosu AL, Brunner T. Impact of a low FODMAP diet on the amount of rectal gas and rectal volume during radiotherapy in patients with prostate cancer - a prospective pilot study. Radiat Oncol. 2020 Jan 30;15(1):27. doi: 10.1186/s13014-020-1474-y. PMID: 32000818; PMCID: PMC6993432.

[28] Valdagni R, Rancati T. Reducing rectal injury during external beam radiotherapy for prostate cancer. Nat Rev Urol. 2013 Jun;10(6):345-57. doi: 10.1038/nrurol.2013.96. Epub 2013 May 14. PMID: 23670182.

[29] Zaira G, Asia G. Breast cancer: the road to a personalized prevention. IgMin Res. 2024;2:163-70.

[30] Prades J, Remue E, van Hoof E, Borras JM. Is it worth reorganising cancer services on the basis of multidisciplinary teams (MDTs)? A systematic review of the objectives and organisation of MDTs and their impact on patient outcomes. Health Policy. 2015 Apr;119(4):464-74. doi: 10.1016/j.healthpol.2014.09.006. Epub 2014 Sep 18. PMID: 25271171.

[31] Capobianco AML, Gallucci G, Lapadula L, Dinardo G, La Torre G, Sisti N, Sisti LG. Impact of the Multidisciplinary Cancer Team on the Diagnostic and Therapeutic Care Pathway of Early Breast Cancer Patients and Perception of Team Members: The Experience of a Cancer Centre in Italy. Cancer Invest. 2024 Jan;42(1):12-20. doi: 10.1080/07357907.2023.2300442. Epub 2024 Jan 22. PMID: 38149612.

[32] Lyman GH, Baker J, Geradts J, Horton J, Kimmick G, Peppercorn J, Pruitt S, Scheri RP, Hwang ES. Multidisciplinary care of patients with early-stage breast cancer. Surg Oncol Clin N Am. 2013 Apr;22(2):299-317. doi: 10.1016/j.soc.2012.12.005. Epub 2013 Jan 3. PMID: 23453336.

[33] Kočo L, Weekenstroo HHA, Lambregts DMJ, Sedelaar JPM, Prokop M, Fütterer JJ, Mann RM. The Effects of Multidisciplinary Team Meetings on Clinical Practice for Colorectal, Lung, Prostate and Breast Cancer: A Systematic Review. Cancers (Basel). 2021 Aug 18;13(16):4159. doi: 10.3390/cancers13164159. PMID: 34439312; PMCID: PMC8394238.

[34] El Hamsas EY, Omaima B, Zineb S, Najat EA, Driss R. The antioxidant and antidepressant properties of dietary proteins derived from egg and bean extracts and their acute toxicity: a journey from nutrition to pharmacognosy. IgMin Res. 2023;1:032-42.

[35] Steingart AB, Cotterchio M. Do antidepressants cause, promote, or inhibit cancers? J Clin Epidemiol. 1995 Nov;48(11):1407-12. doi: 10.1016/0895-4356(95)00545-5. PMID: 7490604.

[36] Zhuang Y, Pang X, Qi Y, Zhang T, Cao G, Xue H, Xu Y, Xie S, Liu Y, Wang Y, Li Y, Xiong Y, Li Y, Shen H. The incidence risk of breast and gynecological cancer by antidepressant use: A systematic review and dose-response meta-analysis of epidemiological studies involving 160,727 patients. Front Oncol. 2022 Oct 14;12:939636. doi: 10.3389/fonc.2022.939636. PMID: 36425551; PMCID: PMC9680975.

[37] Abadi B, Shahsavani Y, Faramarzpour M, Rezaei N, Rahimi HR. Antidepressants with anti-tumor potential in treating glioblastoma: A narrative review. Fundam Clin Pharmacol. 2022 Feb;36(1):35-48. doi: 10.1111/fcp.12712. Epub 2021 Jul 29. PMID: 34212424.

[38] Luo M, Zhou L, Huang Z, Li B, Nice EC, Xu J, Huang C. Antioxidant Therapy in Cancer: Rationale and Progress. Antioxidants (Basel). 2022 Jun 8;11(6):1128. doi: 10.3390/antiox11061128. PMID: 35740025; PMCID: PMC9220137.

[39] Liao J, Li X, Gan Y, Han S, Rong P, Wang W, Li W, Zhou L. Artificial intelligence assists precision medicine in cancer treatment. Front Oncol. 2023 Jan 4;12:998222. doi: 10.3389/fonc.2022.998222. PMID: 36686757; PMCID: PMC9846804.

[40] Rezayi S, R Niakan Kalhori S, Saeedi S. Effectiveness of Artificial Intelligence for Personalized Medicine in Neoplasms: A Systematic Review. Biomed Res Int. 2022 Apr 7;2022:7842566. doi: 10.1155/2022/7842566. PMID: 35434134; PMCID: PMC9010213.

[41] Bhinder B, Gilvary C, Madhukar NS, Elemento O. Artificial Intelligence in Cancer Research and Precision Medicine. Cancer Discov. 2021 Apr;11(4):900-915. doi: 10.1158/2159-8290.CD-21-0090. PMID: 33811123; PMCID: PMC8034385.

[42] Ho D. Artificial intelligence in cancer therapy. Science. 2020 Feb 28;367(6481):982-983. doi: 10.1126/science.aaz3023. PMID: 32108102.

[43] Chen ZH, Lin L, Wu CF, Li CF, Xu RH, Sun Y. Artificial intelligence for assisting cancer diagnosis and treatment in the era of precision medicine. Cancer Commun (Lond). 2021 Nov;41(11):1100-1115. doi: 10.1002/cac2.12215. Epub 2021 Oct 6. PMID: 34613667; PMCID: PMC8626610.

[44] Cè M, Irmici G, Foschini C, Danesini GM, Falsitta LV, Serio ML, Fontana A, Martinenghi C, Oliva G, Cellina M. Artificial Intelligence in Brain Tumor Imaging: A Step toward Personalized Medicine. Curr Oncol. 2023 Feb 22;30(3):2673-2701. doi: 10.3390/curroncol30030203. PMID: 36975416; PMCID: PMC10047107.

Subjects Content

Members Content

Articles Content

Explore Content

私たちを識別する

今すぐ公開する

方針

原稿のガイドライン

電子書籍

その他のサービス

Identify Us

Search

Explore Section

END

The Intersection of Artificial Intelligence in Public Health and Personalized Cancer Therapy

Affiliation

要約

数字